Primary melanomas at the cerebellopontine (CP) angle are extremely rare and considered a diagnostic dilemma. With only 16 prior cases reported so far, there is not enough material in world literature. We report a 29-year-old male who presented with vertigo, headache and features of lower cranial nerve involvement with MRI revealing a melanotic lesion at CP angle. The patient underwent right suboccipital craniectomy and only subtotal excision of the tumor was possible. Histopathologically it turned out to be malignant melanoma. Since a thorough search for any possible primary was futile, it was considered a primary melanoma. Patient was given adjuvant radiotherapy. Ten months later, he presented with weakness and multiple spinal metastases and two months later he succumbed to his disease. We did a comprehensive review of literature about various melanocytic tumors at the CP angle. Pathologically, melanocytic tumors range from benign melanocytomas to malignant melanoma with variable prognosis. The clinical presentation depends upon whether the lesions are diffuse or discrete. Surgery is the primary modality of treatment and the amount of tumor excised is related to the prognosis. We conclude the discussion with a novel classification for melanotic tumors of CNS and the current diagnostic pathway for a melanotic lesion at the CP angle.
InTRoduCTIon
Primary melanocytic tumors of the CNS are rare and have an estimated incidence of 0.9 per 10 million (13). They vary from benign to malignant. Virchow described the first case of primary diffuse intracranial melanoma in 1859 and Oogle (2, 14) reported the first case of primary intracranial solitary melanoma in 1899. Since then, there have been only 250 cases of primary intracranial melanoma reported by WHO (8) . The common sites for a primary CNS melanoma are, lobar (53.1%), posterior fossa (17.3%) and pineal region (13.6%) (2) . Primary melanoma of the cerebellopontine angle is very rare and was first described in 1948 by Bailey (2) . There are only seventeen CP angle melanoma cases reported including the present case (Table I) .
CASE REPoRT
A 29-year-old male presented with diminished hearing on right side, vertigo and loss of taste for five months. He had recurrent aspirations and change of voice for the past two months and unsteadiness of gait for the last month. He also complained of occasional headache. On examination, his higher mental functions were normal. He had a right lower motor neuron type of facial palsy (House-Brackmann grade II), right palatal palsy and nystagmus. There was loss of taste on the right half of the tongue and severe sensory neural hearing loss on the right side. Due to features of seventh and eighth cranial nerve involvement and cerebellar signs, a diagnosis of cerebellopontine (CP) angle tumor was made and MRI was performed.
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Magnetic Resonance Imaging (MRI) revealed a hypointense lesion in the right cerebellopontine cistern on T2-weighted images that was hyperintense on T1-weighted images (Figures 1, 2) . The lesion showed minimal enhancement after contrast infusion. Magnetic Resonance Spectroscopy (MRS) demonstrated minimal increase in the choline/NAA ratio and significant elevation of lactate. The possibility of a benign melanin tumor was offered by the radiologist. However, due to the clinical picture we presumed the diagnosis to be either a malignant melanoma or a melanotic schwannoma.
After preoperative work up, the patient was scheduled for right suboccipital craniectomy. Intraoperatively, the lesion was found to be firm and tough. It was not easily removed either with suction or CUSA. The lesion had to be cut and removed using cutting loupes. The bulk of the tumor was removed, leaving behind a margin of the tumor close to the brainstem ( Figures 3, 4, 5) .
Microscopic examination revealed a cellular neoplasia composed of large cells with vesicular nuclei and prominent nucleoli. Several cells showed dense intra-cytoplasmic deposits of melanin pigment. The mitotic rate was high, about 7/10 HPF and focal areas of necrosis were seen (Figures 6, 7). Thus a diagnosis of malignant melanoma was made. A thorough search of the primary consisting of dermatological evaluation, ophthalmological evaluation, X-ray of the chest and ultrasonography of abdomen was fruitless. We therefore concluded the lesion to be primary melanoma of the cerebellopontine angle.
The immediate postoperative stage was uneventful. The patient was given adjuvant radiotherapy of 5220 cGy over 29 cycles. At two-month follow up the patient remained asymptomatic but follow up Computed Axial Tomography (CAT) showed the presence of tumor remnant ( Figure 8 ). After ten months, the patient presented with weakness in both lower limbs. MRI showed residual tumor and multiple spinal 
melanin is similar to skin melanin and different from neuromelanin, which is found exclusively in neurons. The largest concentration of melanocytes is on the piamater surrounding the medulla and high cervical cord (1) , and this may reflect the common location of melanocytomas.
Some authors have proposed that dural melanomas may have a possible origin from leptomeningeal deposits where the leptomeninges penetrate into the dura (4). Alternately, heterotopic tissues have been described in dura mater and it is possible for a melanoma to arise from a heterotopic mass of melanocyte producing neural crest cells (9) .
Pathology:
Depending on the biological behavior, Melanocytomas are classified into: All three types are immunoreactive for HMB-45 and S-100 protein and negative for epithelial membrane antigen (3).
Clinical Presentation:
Melanomas of the CNS have a peak at the 4 th -5 th decades and have a male preponderance. Like all melanomas they are less common in blacks (2) . Gibson in 1957 classified primary leptomeningeal melanoma into two groups (9): Group A or diffuse variety is the rarer one, and more common in adults than in children. In children they are associated with neurocutaneous melanosis (5) . Clinically they present with features of raised intracranial pressure and are difficult to metastases ( Figure 9 ). Spinal radiation was given which lead to some improvement in motor function of the lower limbs. However the patient succumbed to his illness one year after diagnosis.
dISCuSSIon
Leptomeningeal melanocytes are derived from the neural crest during early embryonic development. Melanocytic peutic agents like Temozolamide and decarbazine were used in metastatic melanoma. (7) . RT using fractionized irradiation in high doses has improved response rates for melanomas (10) . Gamma knife radiotherapy has shown some benefit in intermediate grade melanocytomas. (4) Among chemotherapeutic agents, DTIC when used along with 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU), and vincristine with OK 432 (picibanil) has shown promising results. (10) .
Prognosis:
Melanomas are notorious for their dismal prognosis. The average survival figures for various melanocytic lesions are shown in Table II. pick up on CT/MRI. The antemortem diagnosis is notoriously difficult and it mimics a variety of conditions like lymphoma, leukemia, metastatic carcinoma, subacute meningitis, viral encephalitis, and idiopathic hypertrophic cranial pachymeningitis (12) . Group B or the discrete variety is the commoner of the two, and presents with features of raised intracranial tension with focal signs and meningism (2) . These cases are easily picked up on CAT/MRI. While they are usually diagnosed as an intracranial space occupying lesion, the exact pathology and malignant nature are difficult to assess preoperatively. They have a relatively better prognosis.
Diagnosis:
The typical CAT finding is a contrast enhancing hyperdense mass. On MRI, the classical finding is of a hyperintense lesion on T1 and hypointense lesion on T2. There have been few cases reported with hypointense T1 and iso-high intese T2 WI. These variations are thought to be due to the degree of paramagnetic effect of stable free radicals in melanin and intratumoral hemorrhage (6) . Although CAT/MRI point towards the presence of melanin, the exact pathology cannot be determined. It is also difficult to determine whether the lesion is benign or malignant. The only clue on imaging is leptomeningeal dissemination, which is difficult to pick up on CAT/ MRI. There is not enough data to suggest any advantage of Magnetic Resonance Spectroscopy (MRS). MRS in our case demonstrated only a minimal increase in choline/ NAA ratio and pointed towards a benign disease.
The final diagnosis is made by the pathologist, based on the mitotic figures, nuclear atypia and MIB 1 index. If the lesion is at the CP angle, like in our case, it must be differentiated from melanotic schwannoma. Melanotic schwannomas are well circumscribed, partly encapsulated lesions characterized by polygonal and vesicular cells with grooved nuclei. These cells also contain abundant melanin pigment.
Immuno-histochemical markers used are S100 (a protein expressed in cells of neural crest origin), HMB 45 (detects melanosomes) and Melan. Among these S100 has high sensitivity while HMB 45 has high specificity. Since melanocytomas of all grades as well as melanin containing tumors like melanotic schwannomas react positively, they help little to differentiate between these pathological types. (12, 6) 
Management:
Surgical excision is the primary mode of treatment. Total excision is better than subtotal excision, not only for melanomas but also in case of melanotic schwannoma and intermediate grade melanoma. (2, 3, 6, 11, 4) . Total excision anyhow would be impeded by involvement of lower cranial nerves and major vessels.
Use of adjuvant therapies do not share such a similar consensus. Traditionally Chemotherapy and Radiotherapy(RT) had no role in primary CNS melanomas, while some chemothera- The factors determining prognosis are, type of lesion, Involvement of lepromeninges, Amount of tumor excised and MIB 1 index. Among these the most significant one is MIB 1 index.
ConCLuSIon
After a review of literature we offer the following classification for Melanotic tumors of CNS: 
